464 related articles for article (PubMed ID: 19046193)
1. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
Inoue K; Matsumoto M; Akimoto K
Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
[TBL] [Abstract][Full Text] [Related]
2. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
[TBL] [Abstract][Full Text] [Related]
3. HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
Nair M; Prabhakaran D; Narayan KM; Sinha R; Lakshmy R; Devasenapathy N; Daniel CR; Gupta R; George PS; Mathew A; Tandon N; Reddy KS
Prim Care Diabetes; 2011 Jul; 5(2):95-102. PubMed ID: 21474403
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
[TBL] [Abstract][Full Text] [Related]
5. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
[TBL] [Abstract][Full Text] [Related]
6. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
7. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
Jesudason DR; Dunstan K; Leong D; Wittert GA
Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
[TBL] [Abstract][Full Text] [Related]
8. The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers.
Inoue K; Matsumoto M; Kobayashi Y
Diabetes Res Clin Pract; 2007 Sep; 77(3):451-8. PubMed ID: 17346846
[TBL] [Abstract][Full Text] [Related]
9. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
[TBL] [Abstract][Full Text] [Related]
10. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
[TBL] [Abstract][Full Text] [Related]
11. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.
Bennett CM; Guo M; Dharmage SC
Diabet Med; 2007 Apr; 24(4):333-43. PubMed ID: 17367307
[TBL] [Abstract][Full Text] [Related]
12. Hba(1c) as a tool for the diagnosis of type 2 diabetes: comparison with fasting glucose.
Tatsch E; Bochi GV; Piva SJ; Pereira RS; Kober H; De Carvalho JA; Sangoi MB; Duarte MM; Moresco RN
Clin Lab; 2012; 58(3-4):347-50. PubMed ID: 22582512
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
Gołembiewska E
Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.
Kharroubi AT; Darwish HM; Abu Al-Halaweh AI; Khammash UM
PLoS One; 2014; 9(2):e88123. PubMed ID: 24505401
[TBL] [Abstract][Full Text] [Related]
15. Effect of HbA1c combined FPG on screening diabetes in health check-up.
Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
[TBL] [Abstract][Full Text] [Related]
16. HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).
Valdés S; Botas P; Delgado E; Alvarez F; Díaz-Cadórniga F
Diabetes Metab; 2011 Feb; 37(1):27-32. PubMed ID: 20934897
[TBL] [Abstract][Full Text] [Related]
17. Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations.
Manley SE; Sikaris KA; Lu ZX; Nightingale PG; Stratton IM; Round RA; Baskar V; Gough SC; Smith JM
Diabet Med; 2009 Feb; 26(2):115-21. PubMed ID: 19236612
[TBL] [Abstract][Full Text] [Related]
18. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study.
Wang W; Lee ET; Howard BV; Fabsitz RR; Devereux RB; Welty TK
Diabetes Care; 2011 Feb; 34(2):363-8. PubMed ID: 21270194
[TBL] [Abstract][Full Text] [Related]
19. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
[TBL] [Abstract][Full Text] [Related]
20. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
